Experts
Stories by Tim Boreham
Health & Biotech
Dr Boreham’s Crucible: Will the FDA bend the knee after Paradigm’s Phase III tests?
Experts
CRITERION: Taking a punt on gambling stocks? It’s not as black and red as it used to be
News
CRITERION: Fear a falling market? Maybe an ‘anti-market’ ETF is the hedge you’re looking for
Health & Biotech
Dr Boreham’s Crucible: With sales success, does LBT have the world on a plate?
News
CRITERION: Investing in aged care – it never gets old
Health & Biotech
Dr Boreham’s Crucible: Will AstraZeneca cash put Starpharma on a rocket back to all-time highs?
News
CRITERION: Supply yips and inflation hits foodies but so far it’s just small(er) beer. So far
News
CRITERION: All in favour of a post-election stock market boom say ‘Aye’
Health & Biotech
CRITERION: Are the thrills worth the spills on the small cap rollercoaster right now? Maybe…
News
CRITERION: Tim Boreham’s back with some heavily discounted ecommerce stocks
Health & Biotech